Financhill
Back

Iovance Biotherapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46

IOVA
Iovance Biotherapeutics, Inc.

Last Price:
$2.88
Seasonality Move:
144.47%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IOVA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Iovance Biotherapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.67 Buy
20-day SMA: 2.65 Buy
50-day SMA: 2.56 Buy
200-day SMA: 2.32 Buy
8-day EMA: 2.66 Buy
20-day EMA: 2.11 Buy
50-day EMA: 1.24 Buy
200-day EMA: 0.39 Buy

Iovance Biotherapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 61.32 Buy
Chaikin Money Flow: 6562114 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.44 - 2.78) Buy
Bollinger Bands (100): (2.15 - 2.65) Buy

Iovance Biotherapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Iovance Biotherapeutics, Inc. Stock

Is Iovance Biotherapeutics, Inc. Stock a Buy?

IOVA Technical Analysis vs Fundamental Analysis

Sell
46
Iovance Biotherapeutics, Inc. (IOVA) is a Sell

Is Iovance Biotherapeutics, Inc. a Buy or a Sell?

Iovance Biotherapeutics, Inc. Stock Info

Market Cap:
1.1B
Price in USD:
2.87
Share Volume:
9.2M

Iovance Biotherapeutics, Inc. 52-Week Range

52-Week High:
6.09
52-Week Low:
1.64
Sell
46
Iovance Biotherapeutics, Inc. (IOVA) is a Sell

Iovance Biotherapeutics, Inc. Share Price Forecast

Is Iovance Biotherapeutics, Inc. Stock a Buy?

Fundamental Analysis of Iovance Biotherapeutics, Inc.

Is Iovance Biotherapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.29 per share.

Technical Analysis of Iovance Biotherapeutics, Inc.

Should I short Iovance Biotherapeutics, Inc. stock?

* Iovance Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.